HeartBeam, Inc. (BEAT)
Largest Insider Buys in Sector
BEAT Stock Price History Chart
BEAT Stock Performance
About HeartBeam, Inc.
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
Insider Activity of HeartBeam, Inc.
Over the last 12 months, insiders at HeartBeam, Inc. have bought $0 and sold $28,045 worth of HeartBeam, Inc. stock.
On average, over the past 5 years, insiders at HeartBeam, Inc. have bought $100,706 and sold $60,448 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 5,000 shares for transaction amount of $16,846 was made by BROUNSTEIN RICHARD D (Chief Financial Officer) on 2021‑12‑21.
List of Insider Buy and Sell Transactions, HeartBeam, Inc.
| 2024-09-06 | Sale | director | 1,674 0.0048% | $2.34 | $3,917 | +0.43% | ||
| 2024-08-30 | Sale | director | 5,500 0.0156% | $2.31 | $12,705 | -1.28% | ||
| 2024-08-27 | Sale | director | 2,194 0.0061% | $2.26 | $4,958 | +2.89% | ||
| 2024-08-26 | Sale | director | 300 0.0009% | $2.38 | $714 | +1.76% | ||
| 2024-08-23 | Sale | director | 2,500 0.007% | $2.30 | $5,750 | -1.70% | ||
| 2023-09-29 | Sale | director | 5,500 0.0139% | $2.06 | $11,330 | -3.26% | ||
| 2023-09-28 | Sale | director | 8,000 0.02% | $2.04 | $16,320 | +2.45% | ||
| 2023-09-27 | Sale | director | 1,834 0.0047% | $2.11 | $3,870 | -0.48% | ||
| 2023-09-26 | Sale | director | 5,000 0.0128% | $2.09 | $10,450 | -1.89% | ||
| 2023-09-22 | Sale | director | 2,393 0.0065% | $2.21 | $5,289 | -3.70% | ||
| 2023-09-21 | Sale | director | 100 0.0003% | $2.41 | $241 | -7.93% | ||
| 2023-09-20 | Sale | director | 883 0.0027% | $2.46 | $2,172 | -11.81% | ||
| 2023-09-18 | Sale | director | 5,000 0.0151% | $2.46 | $12,300 | -16.73% | ||
| 2023-09-15 | Sale | director | 4,269 0.0127% | $2.43 | $10,374 | -15.04% | ||
| 2023-09-14 | Sale | director | 5,000 0.0133% | $2.17 | $10,850 | -15.04% | ||
| 2023-09-13 | Sale | director | 5,000 0.0118% | $1.93 | $9,656 | +7.73% | ||
| 2021-12-21 | Chief Financial Officer | 5,000 0.0206% | $3.37 | $16,846 | -51.25% | |||
| 2021-11-11 | CHIEF FINANCIAL OFFICER | 5,000 0.0367% | $5.99 | $29,950 | -62.58% | |||
| 2021-11-11 | director | 9,000 0.0661% | $5.99 | $53,910 | -62.58% | |||
| 2019-12-31 | Sale | SVP & General Counsel | 5,065 0.2894% | $46.62 | $236,130 | -3.20% |
Insider Historical Profitability
| de Urioste George | director | 57146 0.2143% | $2.15 | 0 | 16 | |
| Guidant Investment CORP | 10 percent owner | 787873 2.9547% | $2.15 | 0 | 1 | |
| Capper Joseph H | President & CEO | 178355 0.6689% | $2.15 | 12 | 20 | +16.88% |
| GORMAN KIRK E | director | 173315 0.65% | $2.15 | 4 | 6 | <0.0001% |
| PRYSTOWSKY ERIC N | director | 125706 0.4714% | $2.15 | 1 | 5 | <0.0001% |
| BROUNSTEIN RICHARD D | Chief Financial Officer | 102075 0.3828% | $2.15 | 2 | 0 | <0.0001% |
| THURMAN RANDY H | Chairman, President & CEO | 62536 0.2345% | $2.15 | 1 | 0 | <0.0001% |
| Broadway Fred | President BioTel Heart | 24880 0.0933% | $2.15 | 0 | 20 | |
| Ortigas-Wedekind Marga | director | 16824 0.0631% | $2.15 | 1 | 0 | <0.0001% |
| GALVAN MARTIN P | Chief Financial Officer | 11019 0.0413% | $2.15 | 2 | 0 | <0.0001% |
| MIDDLETON FRED A | director | 8550 0.0321% | $2.15 | 0 | 2 | |
| Ferola Peter | SVP & General Counsel | 8507 0.0319% | $2.15 | 0 | 19 | |
| Sanderling Venture Partners IV, L.P. | 10 percent owner | 2370 0.0089% | $2.15 | 0 | 1 |